316 related articles for article (PubMed ID: 33339254)
1. Spontaneous Formation of Melanin from Dopamine in the Presence of Iron.
Hedges DM; Yorgason JT; Perez AW; Schilaty ND; Williams BM; Watt RK; Steffensen SC
Antioxidants (Basel); 2020 Dec; 9(12):. PubMed ID: 33339254
[TBL] [Abstract][Full Text] [Related]
2. The role of tyrosine hydroxylase as a key player in neuromelanin synthesis and the association of neuromelanin with Parkinson's disease.
Nagatsu T; Nakashima A; Watanabe H; Ito S; Wakamatsu K; Zucca FA; Zecca L; Youdim M; Wulf M; Riederer P; Dijkstra JM
J Neural Transm (Vienna); 2023 May; 130(5):611-625. PubMed ID: 36939908
[TBL] [Abstract][Full Text] [Related]
3. Elucidation of the interplay between Fe(II), Fe(III), and dopamine with relevance to iron solubilization and reactive oxygen species generation by catecholamines.
Sun Y; Pham AN; Waite TD
J Neurochem; 2016 Jun; 137(6):955-68. PubMed ID: 26991725
[TBL] [Abstract][Full Text] [Related]
4. Dopamine-melanin induces apoptosis in PC12 cells; possible implications for the etiology of Parkinson's disease.
Offen D; Ziv I; Barzilai A; Gorodin S; Glater E; Hochman A; Melamed E
Neurochem Int; 1997 Aug; 31(2):207-16. PubMed ID: 9220453
[TBL] [Abstract][Full Text] [Related]
5. l-3,4-dihydroxyphenylalanine (l-DOPA) modulates brain iron, dopaminergic neurodegeneration and motor dysfunction in iron overload and mutant alpha-synuclein mouse models of Parkinson's disease.
Billings JL; Gordon SL; Rawling T; Doble PA; Bush AI; Adlard PA; Finkelstein DI; Hare DJ
J Neurochem; 2019 Jul; 150(1):88-106. PubMed ID: 30716176
[TBL] [Abstract][Full Text] [Related]
6. The Oxidative Pathway to Dopamine-Protein Conjugates and Their Pro-Oxidant Activities: Implications for the Neurodegeneration of Parkinson's Disease.
Wakamatsu K; Nakao K; Tanaka H; Kitahori Y; Tanaka Y; Ojika M; Ito S
Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31130632
[TBL] [Abstract][Full Text] [Related]
7. Cav1.3 channels control D2-autoreceptor responses via NCS-1 in substantia nigra dopamine neurons.
Dragicevic E; Poetschke C; Duda J; Schlaudraff F; Lammel S; Schiemann J; Fauler M; Hetzel A; Watanabe M; Lujan R; Malenka RC; Striessnig J; Liss B
Brain; 2014 Aug; 137(Pt 8):2287-302. PubMed ID: 24934288
[TBL] [Abstract][Full Text] [Related]
8. Glutathione redox status in mitochondria and cytoplasm differentially and sequentially activates apoptosis cascade in dopamine-melanin-treated SH-SY5Y cells.
Naoi M; Yi H; Maruyama W; Inaba K; Shamoto-Nagai M; Akao Y; Gerlach M; Riederer P
Neurosci Lett; 2009 Nov; 465(2):118-22. PubMed ID: 19737600
[TBL] [Abstract][Full Text] [Related]
9. Neuromelanin in Parkinson's Disease: Tyrosine Hydroxylase and Tyrosinase.
Nagatsu T; Nakashima A; Watanabe H; Ito S; Wakamatsu K
Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35456994
[TBL] [Abstract][Full Text] [Related]
10. Differential sensitivity to hydrogen peroxide of dopaminergic and noradrenergic neurotransmission in rat brain slices.
Langeveld CH; Schepens E; Stoof JC; Bast A; Drukarch B
Free Radic Biol Med; 1995 Aug; 19(2):209-17. PubMed ID: 7649492
[TBL] [Abstract][Full Text] [Related]
11. Conjugates of catecholamines with cysteine and GSH in Parkinson's disease: possible mechanisms of formation involving reactive oxygen species.
Spencer JP; Jenner P; Daniel SE; Lees AJ; Marsden DC; Halliwell B
J Neurochem; 1998 Nov; 71(5):2112-22. PubMed ID: 9798937
[TBL] [Abstract][Full Text] [Related]
12. Selectivity of melaninized nigra-striatal dopamine neurons to degeneration in Parkinson's disease may depend on iron-melanin interaction.
Ben-Shachar D; Youdim MB
J Neural Transm Suppl; 1990; 29():251-8. PubMed ID: 2193109
[TBL] [Abstract][Full Text] [Related]
13. Modulation of somatodendritic dopamine release by endogenous H(2)O(2): susceptibility in substantia nigra but resistance in VTA.
Chen BT; Avshalumov MV; Rice ME
J Neurophysiol; 2002 Feb; 87(2):1155-8. PubMed ID: 11826083
[TBL] [Abstract][Full Text] [Related]
14. The role of transition metals in the pathogenesis of Parkinson's disease.
Kienzl E; Puchinger L; Jellinger K; Linert W; Stachelberger H; Jameson RF
J Neurol Sci; 1995 Dec; 134 Suppl():69-78. PubMed ID: 8847547
[TBL] [Abstract][Full Text] [Related]
15. Quantitation of hydrogen peroxide fluctuations and their modulation of dopamine dynamics in the rat dorsal striatum using fast-scan cyclic voltammetry.
Spanos M; Gras-Najjar J; Letchworth JM; Sanford AL; Toups JV; Sombers LA
ACS Chem Neurosci; 2013 May; 4(5):782-9. PubMed ID: 23556461
[TBL] [Abstract][Full Text] [Related]
16. Iron and copper ions accelerate and modify dopamine oxidation to eumelanin: implications for neuromelanin genesis.
Ito S; Napolitano A; Sarna T; Wakamatsu K
J Neural Transm (Vienna); 2023 Jan; 130(1):29-42. PubMed ID: 36527527
[TBL] [Abstract][Full Text] [Related]
17. The enigma of neuromelanin in Parkinson's disease substantia nigra.
Youdim MB; Ben-Shachar D; Riederer P
J Neural Transm Suppl; 1994; 43():113-22. PubMed ID: 7884393
[TBL] [Abstract][Full Text] [Related]
18. Heterogeneity of electrically evoked dopamine release and reuptake in substantia nigra, ventral tegmental area, and striatum.
Cragg S; Rice ME; Greenfield SA
J Neurophysiol; 1997 Feb; 77(2):863-73. PubMed ID: 9065855
[TBL] [Abstract][Full Text] [Related]
19. Glutathione is involved in the granular storage of dopamine in rat PC 12 pheochromocytoma cells: implications for the pathogenesis of Parkinson's disease.
Drukarch B; Jongenelen CA; Schepens E; Langeveld CH; Stoof JC
J Neurosci; 1996 Oct; 16(19):6038-45. PubMed ID: 8815886
[TBL] [Abstract][Full Text] [Related]
20. Autoxidation and MAO-mediated metabolism of dopamine as a potential cause of oxidative stress: role of ferrous and ferric ions.
Hermida-Ameijeiras A; Méndez-Alvarez E; Sánchez-Iglesias S; Sanmartín-Suárez C; Soto-Otero R
Neurochem Int; 2004 Jul; 45(1):103-16. PubMed ID: 15082228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
